Connective Tissue Diseases Flashcards
CTDs (general)
A group of systemic autoimmune rheumatic diseases May be associated with arthropathy, but the hallmarks of these diseases are multiorgan and systemic involvement, and autoimmunity
Types of CTDs (5)
Systemic Lupus Erythematosus (SLE) Sjogren’s Syndrome Scleroderma - Progressive Systemic Sclerosis - Limited Scleroderma/CREST Inflammatory Myopathies - Polymyositis - Dermatomyositis Undifferentiated CTD
SLE
- Patho
- Labs
Systemic Lupus Erythematosus
Patho:
- unknown etiology
- MC in women
- genetic predisposition
- antigen-antibody complexes with with complement binding and immune complex deposition in skin and glomeruli
Labs:
- Antibody Antinuclear Antibodies (ANA)
- antibodies that bind to nuclear antigens; seen in most CTDs; sensitive but not specific
- Anti-ds-DNA (ds-DNA):
- correlates with renal disease and disease activity; specific to SLE
- Complements:
- serum proteins involved with immune response that are abnormally low
- Extractable Nuclear Antigens (ENA):
- complete panel that allows delineation of which CTD
*Use theses tests to help establish dx, determine dz activity, assess organ involvement, monitor therapeutic response. Pt must have PE significant for dz too.
SLE Classification Criteria (11)
- Malar rash
- discoid rash
- photosensitivity
- oral ulcers
- arthritis
- arthralgias, myalgias, inflammatory polyarthritis (non-erosive, reversible joint deformity - Jaccoud’s arthropathy)
- serositis (pleuritis or pericarditis)
- Nephritis
- can be variable: persistent proteinuria and cellular casts, dysmorphic RBC, dec GFR
- Neuro disorder
- seizures, psychosis, cognitive deficits, depression, strokes, HA, aspetic meningitis
- Hematologic disorder
- cytopenia, coagulopathy (may lead to thrombosis, antiphospholipid antibodies indicate this state)
- Positive ANA
- Other positive antibodies
Must have 4/11
SLE Treatment (4)
based on manifestations and organ involvement
NSAIDs for m/s
Sun protection
Glucocorticoids–bridge therapy
Steroid sparing agents like Methotrexate or Hydroxychlorquine
Sjogren’s Syndrome
- Patho
- Labs
- Signs/Sxs
- Dx
- Tx
Patho:
- lymphocytic infiltration of lacrimal and salivary glands
- primary SS - no other autoimmune disorders
- secondary SS - presence of other autoimmune disorders
- MC in females
Labs:
- +/- ANA
- Rh
Signs/Sxs:
- xeropthalmia (Schirmer’s test)
- xerostomia (–>dental carries)
- parotid enlargement
- nonerosive systemic arthralgias
- fibromyalgia
- cardiopulmonary, neuro, renal, lymphadenopathy
Dx
- usually clinically
- salivary gland/parotid bx
Tx
- depends on systems involved
- eye drops, saliva substitutes (mostly here)
- NSAIDs
- hydroxychlorquine
Scleroderma
- patho
- classification (2)
- clinical manifestations (6)
- treatment
Patho
- collagen deposition in skin, vessels, GI tract, renal, cardiopulmonary organs
Classification
- Limited Scleroderma/CREST
- Calcinosis
- Raynaud’s
- Esophageal dysmotility
- Sclerodactyly
- Telangiectasias
- Characterized by distal sclerosis
- Diffuse/Progressive Systemic Sclerosis (PSS)
- proximal and distal sclerosis
Clinical Manifestations Common to both Classifications
- Raynaud’s
- Interstitial lung disease
- Pulmonary HTN
- Renal
- GI (reflux, dysphagia, decreased peristalsis, bacerial overgrowth
- M/S (sclerodactyly, acrosclerosis)
Treatment:
- Not effective
- PT/OT
- DMARDs
Inflammatory Myopathies
- Patho
- Labs
- Diagnostic Criteria (5)
- Clinical Signs (other things you may see)
- Treatment
Patho
- Inflammatory immune mediated proximal muscle weakness of unknown etiology
Labs
- elevated muscle enzymes (CPK, aldolase, AST, ALT, LDH)
Diagnostic Criteria
- proximal muscle weakness
- elevated muscle enzymes
- myopathic changes on EMG
- muscle bx evidence of myositis
- skin rash
Clinical Signs
- Dysphagia
- Interstitial lung disease
- Arthralgias
- Raynaud’s phenomenon
- Skin manifestations of DM
- heliotrope rash
- **V or shawl sign **
- Gottron’s papules
Treatment
- prednisone, MTX, PT
- follow muscle enzymes and strength
Mixed CTD
Undifferentiated CTD
Overlap CTD
Mixed: has features of multiple CTDs
Undifferentiated CTD: lack a single unifying diagnosis but rather have features of several diseases
Overlap CTD: meet the criteria for 2 or more